Maria Cristina De Salvo, M.D., Ph.D. – FDA Inspection, Mar 21, 2025

Record Details

This FDA Inspection record concerns Maria Cristina De Salvo, M.D., Ph.D., with an inspection on March 21, 2025, issued by the Office of Inspections and Investigations, covering human drugs.

Company: Maria Cristina De Salvo, M.D., Ph.D.
Inspection Date: March 21, 2025
Product Type: Human Drugs
Office: Office of Inspections and Investigations
People: Emily A. Baldwin (Company Rep)
Habacuc V. Barrera (Issuing Officer)

View Company Profile

ID · e27da7fd-ebfb-41c2-85ce-a72e8010f2db

Inspection Facts

Inspection number: 1266205
FDA center: Human Drugs

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Maria Cristina De Salvo, M.D., Ph.D.

FDA Inspection

Maria Cristina De Salvo, M.D., Ph.D.March 21, 2025

Maria Cristina De Salvo, M.D., Ph.D. – FDA Inspection, Mar 21, 2025

Record Details

This FDA Inspection record concerns Maria Cristina De Salvo, M.D., Ph.D., with an inspection on March 21, 2025, issued by the Office of Inspections and Investigations, covering human drugs.